| Pazopanib studied in …STUDIED_INderived200 of 208show all (up to 200) |
|---|
| → studied in | NCT01552356Phase 1 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841736Phase 2 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors · 208 trials list this drug (17 active) | — | — | Neuroendocrine Tumor,Digestive System Neuroendocrine Tumor G1,Foregut Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 208 trials list this drug (17 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263231Phase 3 · recruiting A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01575548Phase 3 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444619Phase 1 · recruiting A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · 208 trials list this drug (17 active) | — | — | Malignant Myoepithelioma,Atypical Fibroxanthoma,Fibrosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029001Phase 2 · recruiting Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment · 208 trials list this drug (17 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217931Phase 2 · active not recruiting Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial · 208 trials list this drug (17 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009449Phase 1 · completed A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087158Phase 2 · recruiting A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05180695Phase 1/Phase 2 · active not recruiting HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · 208 trials list this drug (17 active) | — | — | Fibrohistiocytic Neoplasm,Nerve Sheath Neoplasm,Pericytic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260894Phase 3 · completed Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02331498Phase 1/Phase 2 · active not recruiting Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme · 208 trials list this drug (17 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642017Phase 1 · terminated Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555748Phase 4 · completed Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01684397Phase 1/Phase 2 · active not recruiting Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01931098Phase 2 · completed Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab · 208 trials list this drug (17 active) | — | — | Central Nervous System Neoplasm,Glioblastoma,Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660930Phase 1/Phase 2 · terminated Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03592472Phase 3 · recruiting A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720941Phase 3 · completed Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01147822Phase 2 · completed Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895733Phase 1/Phase 2 · recruiting Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1) · 208 trials list this drug (17 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · 208 trials list this drug (17 active) | — | — | Kidney Oncocytoma,Sarcomatoid Renal Cell Carcinoma,Papillary Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816771Phase 2 · recruiting Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents · 208 trials list this drug (17 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203760Phase 2 · active not recruiting Pazopanib Vs. Pazopanib Plus Gemcitabine · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02207309Phase 2 · terminated Pazopanib Maintenance Phase II · 208 trials list this drug (17 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01402271Phase 1/Phase 2 · completed Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer · 208 trials list this drug (17 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949424Phase 4 · unknown OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults · 208 trials list this drug (17 active) | — | — | Breast Carcinoma,Ovarian Carcinoma,Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00827372Phase 2 · completed A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02383251Phase 2 · completed Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04741438Phase 3 · unknown Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype · 208 trials list this drug (17 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03200717Phase 2 · completed Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430572Phase 1 · completed Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02066285Phase 2 · completed Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma · 208 trials list this drug (17 active) | — | — | Solitary Fibrous Tumor,Extraskeletal Myxoid Chondrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01330966Phase 2 · completed Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma · 208 trials list this drug (17 active) | — | — | Chondrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01407562Phase 1 · terminated Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · 208 trials list this drug (17 active) | — | — | Sarcoma,High Grade Sarcoma,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01462630Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma · 208 trials list this drug (17 active) | — | — | Adult Soft Tissue Sarcoma,Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236547Phase 2 · completed Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer · 208 trials list this drug (17 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01468922Phase 1 · completed Pazopanib and ARQ 197 for Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02450136NA · completed Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02691767NA · completed Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01157091Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · 208 trials list this drug (17 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02357810Phase 2 · completed Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas · 208 trials list this drug (17 active) | — | — | Liposarcoma,Osteosarcoma,Adult Liposarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03334409Phase 2 · terminated Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01566747Phase 2 · completed Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472081Phase 1 · completed Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01035658Phase 1/Phase 2 · terminated Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma · 208 trials list this drug (17 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Sarcoma,Adult Fibrosarcoma,Adult Liposarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392183Phase 2 · completed Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) · 208 trials list this drug (17 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548144Phase 1 · terminated Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02959554Phase 2 · terminated Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465659Phase 1/Phase 2 · completed Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery · 208 trials list this drug (17 active) | — | — | Pancreatic Neuroendocrine Carcinoma,Malignant Pancreatic Gastrinoma,Malignant Pancreatic Glucagonoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02055690Phase 1/Phase 2 · terminated PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Ovarian Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01743482Phase 2 · completed Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors · 208 trials list this drug (17 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960906Phase 2 · completed A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636908NA · completed Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01759303Phase 2 · terminated Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung · 208 trials list this drug (17 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361334Phase 2 · completed Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible · 208 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01610206Phase 2 · completed A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866697Phase 3 · completed Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 208 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02354612no longer available Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01543802Phase 2 · terminated Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03139331Phase 1 · completed PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma · 208 trials list this drug (17 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235962Phase 3 · completed A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02138526Phase 1 · completed Pazopanib Tolerability When Given With Food · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01956669Phase 2 · completed Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02300545Phase 2 · completed Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692496Phase 2 · completed Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial · 208 trials list this drug (17 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649778completed Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02193152Phase 2 · terminated Pazopanib in Molecularly Selected Patients With Advanced NSCLC · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462445Phase 2 · completed Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466972Phase 2 · completed Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib · 208 trials list this drug (17 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02979899Phase 3 · completed Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma · 208 trials list this drug (17 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01446809NA · completed Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · 208 trials list this drug (17 active) | — | — | Multiple Endocrine Neoplasia Type 1,Digestive System Neuroendocrine Tumor G1,Gastrin-Producing Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01221506early Phase 1 · completed Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 208 trials list this drug (17 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02406521Phase 1 · completed Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02014636Phase 1 · completed Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018) · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625846Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer · 208 trials list this drug (17 active) | — | — | Thyroid Gland Anaplastic Carcinoma,Thyroid Gland Medullary Carcinoma,Differentiated Thyroid Gland Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392352Phase 2 · terminated HYPAZ: Hypertension Induced by Pazopanib · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Malignant Digestive System Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571438NA · unknown Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors · 208 trials list this drug (17 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00674024Phase 1 · completed Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function · 208 trials list this drug (17 active) | — | — | Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393820Phase 2 · completed Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma · 208 trials list this drug (17 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02795819Phase 1 · terminated Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer · 208 trials list this drug (17 active) | — | — | Sarcoma,Soft Tissue Sarcoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01184326Phase 1 · completed Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer · 208 trials list this drug (17 active) | — | — | Solid Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00775307Phase 2/Phase 3 · completed Adjuvant Pazopanib in Stage I NSCLC · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247571Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer · 208 trials list this drug (17 active) | — | — | Uterine Corpus Sarcoma,Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01468909Phase 2 · completed Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer · 208 trials list this drug (17 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639911Phase 1 · completed Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors · 208 trials list this drug (17 active) | — | — | Head and Neck Neoplasm,Malignant Breast Neoplasm,Malignant Thoracic Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02575066Phase 2 · terminated Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients · 208 trials list this drug (17 active) | — | — | Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02729194early Phase 1 · completed Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01280201Phase 2 · completed Pazopanib as Single Agent in Advanced NETs · 208 trials list this drug (17 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253369Phase 2 · completed Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer · 208 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01716416Phase 1 · completed Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) · 208 trials list this drug (17 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387205Phase 1 · completed Study To Assess Long Term Safety Of Pazopanib · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01713972Phase 1 · completed Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors · 208 trials list this drug (17 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01503372Phase 2 · completed FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer · 208 trials list this drug (17 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01832259Phase 2 · completed A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection · 208 trials list this drug (17 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861913Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery · 208 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560012Phase 2 · terminated Personalized Targeted Inhibitors Treatment in Renal Cell Cancer · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628131Phase 1/Phase 2 · unknown Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors · 208 trials list this drug (17 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281632Phase 2 · completed A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Malignant Peritoneal Neoplasm,Ovarian Neoplasm,Malignant Fallopian Tube Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158521Phase 2 · completed Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01438554Phase 1 · completed Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma · 208 trials list this drug (17 active) | — | — | Solid Neoplasm,Soft Tissue Sarcoma,Malignant Thyroid Gland Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509587Phase 2 · completed Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01394211Phase 2 · terminated Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275558Phase 1 · withdrawn Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma · 208 trials list this drug (17 active) | — | — | Glioblastoma,Glioma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01208064Phase 2/Phase 3 · terminated Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy · 208 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385228Phase 1 · completed Pazopanib, Docetaxel, Prednisone Prostate · 208 trials list this drug (17 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282579completed Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361113Phase 2 · completed Neoadjuvant Pazopanib in Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01644825Phase 2 · completed Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012362Phase 1 · terminated Study of Pazopanib and Ixabepilone in Patients With Solid Tumors · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Malignant Head and Neck Neoplasm,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01995981completed Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540943Phase 1 · completed Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer · 208 trials list this drug (17 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00158782Phase 1 · completed Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363194Phase 1 · completed A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00370513Phase 1 · completed A Phase I Study of Pazopanib in Adult Patients With Liver Cancer · 208 trials list this drug (17 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387387Phase 1 · completed Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) · 208 trials list this drug (17 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388076Phase 1 · completed Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) · 208 trials list this drug (17 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478725Phase 1 · completed Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00619424Phase 1 · completed A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678977Phase 1 · completed A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861029Phase 1 · completed VEG111485: A QTc Study of Pazopanib · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00401583Phase 1 · completed A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516672Phase 1 · completed Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00722293Phase 1 · completed A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00732420Phase 1 · completed Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866528Phase 1 · completed Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02113826Phase 2 · terminated Pazopanib for Metastatic Alveolar Soft Part Sarcoma · 208 trials list this drug (17 active) | — | — | Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02342600Phase 2 · withdrawn SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor) · 208 trials list this drug (17 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01340794Phase 2 · terminated Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma · 208 trials list this drug (17 active) | — | — | Paraganglioma,Extra-Adrenal Paraganglioma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521715Phase 4 · completed First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01622660Phase 2 · terminated Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy · 208 trials list this drug (17 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03149120Phase 2 · withdrawn Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861951Phase 2 · completed A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02089802Phase 2 · terminated Optimizing Pazopanib Exposure in RCC Patients · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01130623Phase 1 · withdrawn A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors · 208 trials list this drug (17 active) | — | — | Sarcoma,Wilms Tumor,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339871Phase 1 · completed Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01108055Phase 2 · completed Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer · 208 trials list this drug (17 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01599832NA · terminated Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486642Phase 2 · completed Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy · 208 trials list this drug (17 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01524848Phase 2 · completed Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib · 208 trials list this drug (17 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01538238Phase 2 · completed pazopanib_NCRCC,Ph2 STUDY · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064310Phase 3 · completed Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01391611Phase 2 · terminated Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST) · 208 trials list this drug (17 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00800345Phase 1 · completed Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors · 208 trials list this drug (17 active) | — | — | Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244764Phase 2 · completed GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459381Phase 2 · completed Pazopanib in Treating Patients With Recurrent Glioblastoma · 208 trials list this drug (17 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01262820Phase 2 · completed Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab · 208 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506596Phase 2 · completed Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma · 208 trials list this drug (17 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00256880Phase 2 · completed Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02279576Phase 2 · terminated Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) · 208 trials list this drug (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02367651Phase 2 · withdrawn Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02348398Phase 2 · withdrawn Phase II Study of Pazopanib and Topotecan in Cervical Cancer · 208 trials list this drug (17 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01262014Phase 2 · completed Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer · 208 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01059656Phase 2 · terminated Phase II Pazopanib Study in Advanced Dermatofibrosarcomas · 208 trials list this drug (17 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01719302Phase 1/Phase 2 · completed Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01454804Phase 1 · completed Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307474NA · withdrawn A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer · 208 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00347919Phase 2 · completed Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer · 208 trials list this drug (17 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01323400Phase 2 · completed Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) · 208 trials list this drug (17 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454571Phase 2 · completed Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer · 208 trials list this drug (17 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238770Phase 1/Phase 2 · completed Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer · 208 trials list this drug (17 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334282Phase 3 · completed Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00297258Phase 2 · completed Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027598Phase 2 · completed Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01099540Phase 2 · completed Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor · 208 trials list this drug (17 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454142Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer · 208 trials list this drug (17 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413113Phase 1 · completed Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery · 208 trials list this drug (17 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01985295Phase 1 · completed Combined Modality Treatment of Sarcomas of the Extremities · 208 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01713296Phase 2 · completed Pazopanib in Relapsed and Refractory Small Cell Lung Cancer · 208 trials list this drug (17 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01716546Phase 1/Phase 2 · terminated Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer · 208 trials list this drug (17 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01542047Phase 1 · terminated A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080248Phase 2 · terminated Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer · 208 trials list this drug (17 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00731211Phase 2 · completed Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00430781Phase 2 · completed Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer · 208 trials list this drug (17 active) | — | — | Cervical Neoplasm,Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01446224completed Cardiovascular and Torsades de Pointes Monitoring for Pazopanib · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450879Phase 1 · terminated Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788580Phase 1 · withdrawn S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227928Phase 2 · completed Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women · 208 trials list this drug (17 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459862Phase 2 · completed Pazopanib in Treating Patients With Malignant Pleural Mesothelioma · 208 trials list this drug (17 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324803Phase 2 · unknown Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00549328Phase 2 · terminated Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165385Phase 1 · completed Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01313663Phase 2 · terminated A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population · 208 trials list this drug (17 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01049776Phase 2 · terminated GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line · 208 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408004Phase 2 · completed Rotating Pazopanib and Everolimus to Avoid Resistance · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00471536Phase 2 · completed Pazopanib in Treating Patients With Metastatic Urothelial Cancer · 208 trials list this drug (17 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm,Distal Urethral Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01577784Phase 2 · unknown Pazopanib in Second-line Therapy in Renal Cell Carcinoma · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387764Phase 3 · completed Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer · 208 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00945477Phase 2 · terminated Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade · 208 trials list this drug (17 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01060514Phase 1 · terminated Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer · 208 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00929903Phase 1 · completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment · 208 trials list this drug (17 active) | — | — | Childhood Solid Neoplasm,Childhood Central Nervous System Embryonal Tumor,Childhood Central Nervous System Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060151Phase 1 · completed GW786034 in Treating Patients With Advanced Solid Tumors · 208 trials list this drug (17 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |